Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oxygen As an Acute Treatment in Alternating Hemiplegia of Childhood
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Alternating hemiplegia of childhood (AHC) is a rare early-onset neurodevelopmental encephalopathy frequently caused by mutations in the ATP1A3 gene. It is typically characterized by a variable degree of intellectual disability, motor dysfunction and various paroxysmal events (dystonic and plegic attacks). Dystonic and plegic attacks are very disabling and current treatments are disappointing with limited efficacy and poor tolerability. The investigators recently reported the efficacy of high-flow oxygen administration (100% O2 at a flow rate of 12 L/min) as an acute treatment for the dystonic attacks in a 25-year-old patient suffering from AHC. The aim of the study is to assess the effect of high-flow oxygen administration (against placebo) as an acute treatment of dystonic and plegic attacks. The primary outcome will be the proportion of motor attacks stopped 30 minutes after the beginning of motor symptoms over 5 weeks.
Official title: Oxygen Therapy As an Acute Treatment for Dystonic And/or Plegic Attacks in Alternating Hemiplegia of Childhood
Key Details
Gender
All
Age Range
1 Year - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2024-09-16
Completion Date
2025-06
Last Updated
2024-09-27
Healthy Volunteers
No
Conditions
Interventions
Oxygen
High-flow oxygen (12 L/min) administered with a non-rebreathing facial mask, started as soon as possible after the beginning of the attack and for 15 minutes.
Placebo
High-flow medical air (12 L/min) administered with a non-rebreathing facial mask, started as soon as possible after the beginning of the attack and for 15 minutes.
Locations (2)
HCL LYON
Lyon, France
Hôpital Pitié Salpêtrière
Paris, France